North America Analgesics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
North America Analgesics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The North America analgesics market size reached US$ 23.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028.
An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal anti-inflammatory drugs (NSAIDs), such as the salicylates, and opioid drugs, including morphine and oxycodone. Analgesics are taken to relieve pain that can arise from appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc.
The North America analgesics market is currently driven by several factors. The rising geriatric population suffering from incurable health issues, such as joint pain, has stimulated the demand for pain treatment therapies. These therapies employ different types of analgesics, thus catalyzing the market growth in the region. Moreover, the prevalence of osteoarthritis, cardiovascular diseases and cancer have substantially risen in the region, which has also induced the demand for analgesics. Furthermore, the growing number of surgeries, coupled with the penetration of effective pain management medications is expected to fuel the growth of the market during the next few years. Apart from this, availability of analgesics drugs in forms of gels, creams, sprays and oral tablets has made them consumer friendly.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North America analgesics market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on type, drug class, route of administration, pain type and application.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Type
Prescription Analgesics
OTC Analgesics
Market by Drug Class
Opioids
NSAID
Others
Market by Route of Administration
Oral
Parenteral
Topical
Transdermal
Rectal
Market by Pain Type
Musculoskeletal Pain
Surgical and Trauma Pain
Cancer Pain
Neuropathic Pain
Migraine
Obstetrical Pain
Fibromyalgia
Pain due to Burns
Dental/Facial Pain
Pediatric Pain
Others
Market by Application
Internal Analgesics
External Analgesics
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America analgesics market performed so far and how will it perform in the coming years?
What are the key regions in the North America analgesics market?
What has been the impact of COVID-19 on the North America analgesics market?
What is the breakup of the North America analgesics market on the basis of type?
What is the breakup of the North America analgesics market on the basis of drug class?
What is the breakup of the North America analgesics market on the basis of route of administration?
What is the breakup of the North America analgesics market on the basis of pain type?
What is the breakup of the North America analgesics market on the basis of application?
What are the various stages in the value chain of the North America analgesics industry?
What are the key driving factors and challenges in the North America analgesics industry?
What is the structure of the North America analgesics industry and who are the key players?
What is the degree of competition in the North America analgesics industry?
What are the profit margins in the North America analgesics industry?
Table of Contents
142 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1Objectives of the Study
- 2.2Stakeholders
- 2.3Data Sources
- 2.3.1Primary Sources
- 2.3.2Secondary Sources
- 2.4Market Estimation
- 2.4.1Bottom-Up Approach
- 2.4.2Top-Down Approach
- 2.5Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1Overview
- 4.2Key Industry Trends
- 5 Global Analgesics Market
- 5.1Market Performance
- 5.2Market Breakup by Type
- 5.3Market Breakup by Drug Class
- 5.4Market Breakup by Route of Administration
- 5.5Market Breakup by Pain Type
- 5.6Market Breakup by Application
- 5.7Market Breakup by Region
- 5.8Market Forecast
- 6 North America Analgesics Market
- 6.1Market Performance
- 6.2Impact of COVID-19
- 6.3Market Forecast
- 7 North America Analgesics Market: Breakup by Type
- 7.1Prescription Analgesics
- 7.2OTC Analgesics
- 8 North America Analgesics Market: Breakup by Drug Class
- 8.1Opioids
- 8.2NSAID
- 8.3Others
- 9 North America Analgesics Market: Breakup by Route of Administration
- 9.1Oral
- 9.2Parenteral
- 9.3Topical
- 9.4Transdermal
- 9.5Rectal
- 10 North America Analgesics Market: Breakup by Pain Type
- 10.1Musculoskeletal Pain
- 10.2Surgical and Trauma Pain
- 10.3Cancer Pain
- 10.4Neuropathic Pain
- 10.5Migraine
- 10.6Obstetrical Pain
- 10.7Fibromyalgia
- 10.8Pain due to Burns
- 10.9Dental/Facial Pain
- 10.10Pediatric Pain
- 10.11Others
- 11 North America Analgesics Market: Breakup by Application
- 11.1Internal Analgesics
- 11.2External Analgesics
- 12 North America Analgesics Market: Breakup by Country
- 12.1 United States
- 12.1.1Historical market Trends
- 12.1.2Market Breakup by Type
- 12.1.3Market Breakup by Drug Class
- 12.1.4Market Breakup by Route of Administration
- 12.1.5Market Breakup by Pain Type
- 12.1.6Market Breakup by Application
- 12.1.7Market Forecast
- 12.2 Canada
- 12.2.1Historical market Trends
- 12.2.2Market Breakup by Type
- 12.2.3Market Breakup by Drug Class
- 12.2.4Market Breakup by Route of Administration
- 12.2.5Market Breakup by Pain Type
- 12.2.6Market Breakup by Application
- 12.2.7Market Forecast
- 12.3 Mexico
- 12.3.1Historical market Trends
- 12.3.2Market Breakup by Type
- 12.3.3Market Breakup by Drug Class
- 12.3.4Market Breakup by Route of Administration
- 12.3.5Market Breakup by Pain Type
- 12.3.6Market Breakup by Application
- 12.3.7Market Forecast
- 13 SWOT Analysis
- 13.1Overview
- 13.2Strengths
- 13.3Weaknesses
- 13.4Opportunities
- 13.5Threats
- 14 Value Chain Analysis
- 14.1 Overview
- 14.2 Research and Development
- 14.3 Raw Material Procurement
- 14.4 Manufacturing
- 14.5 Marketing
- 14.6 Distribution
- 14.7 End-Use
- 15 Porter’s Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Rivalry
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
- 16 Price Analysis
- 17 Competitive Landscape
- 17.1Market Structure
- 17.2Key Players
- 17.3Profiles of Key Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
